Introduction
Autoimmune diseases
Autoantibodies - Introduction
Autoantibodies - Determination
 
Autoantibodies
Rheumatoid Factor
Antinuclear Antibodies (ANA)
Specific Antibodies
Anti-neutrophil Cytoplasmic Antibodies
(ANCA)
Anti-phospholipid Antibodies
Anti-mitochondrial Antibodies (AMA)
Anti-endothelial Cell Antibodies (AECA)
Anti CCP antibodies
Antibodies against DNases
 
Quality Assurance
 
Reference ranges
 
Algorithm
ANA and incidence of diseases
Proposed stepwise diagnosis scheme
Positive Immunoflourescence -
Nucleoplasmic
Positive Immunoflourescence - Nucleolar
Positive Immunoflourescence -
Cytoplasmic
Type of autoimmune diseases
Conditions associated with antinuclear
antibodies (ANA)
 
Slide show
 
References
 
Collaborators
Anti CCP antibodies - Clinical significance

Citrulline antibody is present in most patients with rheumatoid  arthritis. It is used in the diagnosis of rheumatoid arthritis when evaluating patients with unexplained joint inflammation. A test for citrulline antibodies is most helpful in looking for the cause of previously undiagnosed inflammatory arthritis when the traditional blood test for rheumatoid arthritis, rheumatoid factor, is not present. Citrulline antibodies have been felt to represent the earlier stages of rheumatoid arthritis in this setting.
The anti-CCP test should be useful in identifying patients with early seronegative polyarthritis as individuals with rheumatoid arthritis when the test is positive.

Potential false positives in some tested cases:

  1. Parvoviral Arthropathy, 5%of cases
  2. SLE, 2.5% of cases
  3. Early Synovitis
  4. Hepatitis C
  5. Seronegative Inflammatory Arthropathy
  6. Polymyalgia Rheumatica
  7. Sarcoidosis
  8. Spondyloarthropathy 0/19
  9. Ankylosing Spondylitis
  10. Psoriatic Arthritis
  11. Reiter's Syndrome
  12. Inflammatory Bowel Disease with Arthritis
  13. Undifferentiated Spondyloarthropathy
  14. Fibromyalgia
  15. Remitting Seronegative Symmetrical Synovitis with Pitting Edema
Results should be used in conjunction with other clinical findings to make a diagnosis of rheumatoid arthritis

Reference values (ELISA)
dependent on method

< 20 EU

negative

20 – 39 EU
weak positive
40 - 59 EU
moderate positive

3 69 EU

strong positive